Delivery Order SPE2DB24D1021-SPE2DB25FETBB
Award Date
1/10/25
Potential Completion Date
1/13/25
Potential Value
$32K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to the U.S. government. The contract, valued at $17,588.13, was awarded by the Medical Supply Chain, which is part of the Defense agency.
Amerisourcebergen, a major pharmaceutical distribution company, has been awarded this Firm Fixed Price delivery order contract with a completion date of May 16, 2024. The company holds a...
This federal contract award is for the delivery of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $12,154.39 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 3, 2024 with a completion date of July 5, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML. The $4,408.55 firm-fixed-price delivery order contract has a completion date of December 23, 2021.
Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This...
This federal contract award, valued at $21,075.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026.
The contract covers the procurement of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty medication, to support military healthcare programs. As a general...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,041.46 firm-fixed-price delivery order is for the supply of the drug Rebif 44 mcg/0.5 mL syringe. The contract does not have a set-aside designation, indicating it was competitively awarded.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a specialty pharmaceutical product, REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML. The total ceiling value of this delivery order is $163,843.99. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
This firm-fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $53,763.62 contract is for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and supplier of medical products to the U.S. government. The $12,303.90 firm-fixed-price contract is for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty medication, to support federal healthcare programs and facilities.
AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,938.51 firm fixed price delivery order is for the supply of the specialty medication Rebif 44 mcg/0.5 ml syringe, with a completion date of December 27, 2022.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,611.44, is for the delivery of the prescription drug Rebif Rebidose 44 mcg/0.5 ml. It is a firm fixed-price delivery order with a completion date of February 22, 2022.
Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System...